Cubist Systematic Strategies LLC raised its stake in Appian Co. (NASDAQ:APPN – Get Rating) by 17.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 97,766 shares of the company’s stock after buying an additional 14,750 shares during the quarter. Cubist Systematic Strategies LLC owned approximately 0.13% of Appian worth $3,992,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Abdiel Capital Advisors LP grew its position in Appian by 39.9% in the second quarter. Abdiel Capital Advisors LP now owns 8,328,118 shares of the company’s stock worth $394,420,000 after acquiring an additional 2,375,584 shares during the period. Renaissance Technologies LLC purchased a new position in shares of Appian during the 1st quarter worth $13,983,000. Great West Life Assurance Co. Can acquired a new stake in shares of Appian during the 3rd quarter worth about $6,700,000. Woodline Partners LP purchased a new stake in Appian in the 2nd quarter valued at about $5,860,000. Finally, StackLine Partners LP lifted its position in Appian by 13.0% in the third quarter. StackLine Partners LP now owns 604,139 shares of the company’s stock valued at $24,667,000 after buying an additional 69,655 shares during the last quarter. 50.89% of the stock is owned by institutional investors and hedge funds.
Appian Price Performance
Shares of NASDAQ APPN opened at $44.64 on Monday. The stock’s 50-day moving average is $39.07 and its two-hundred day moving average is $40.87. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.56 and a quick ratio of 1.56. The company has a market cap of $3.25 billion, a price-to-earnings ratio of -21.46 and a beta of 1.63. Appian Co. has a 1-year low of $29.80 and a 1-year high of $66.91.
Insider Buying and Selling
Analyst Upgrades and Downgrades
A number of research firms have recently issued reports on APPN. The Goldman Sachs Group reduced their price target on shares of Appian from $71.00 to $55.00 and set a “buy” rating on the stock in a research note on Monday, November 7th. Barclays boosted their target price on Appian from $25.00 to $30.00 in a research report on Friday, February 17th. Morgan Stanley raised their price target on Appian from $42.00 to $46.00 and gave the stock an “equal weight” rating in a research report on Friday, February 17th. Truist Financial boosted their price objective on Appian from $45.00 to $50.00 and gave the company a “buy” rating in a report on Friday, February 17th. Finally, Sumitomo Mitsui Financial Group cut Appian from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $37.00 to $23.00 in a report on Monday, January 9th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, Appian currently has a consensus rating of “Hold” and an average price target of $45.89.
Appian Profile
Appian Corp. provides business process management (BPM) solutions. Its BPM tools automate and measure business processes. The firm’s products include BPM software, case management, mobile application development, and platform-as-a-service. The company was founded by Matt Calkins, Robert C. Kramer, Marc Wilson, and Michael Beckley in 1999 and is headquartered in McLean, VA.
Further Reading
- Get a free copy of the StockNews.com research report on Appian (APPN)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
Receive News & Ratings for Appian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appian and related companies with MarketBeat.com's FREE daily email newsletter.